Follow The Filings

GL Globe Life Inc.

Financials, filed as GLOBE LIFE INC (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

Bought by 1 manager in 2026 Q2, sold by 3

  • 2 Owners
  • Max 0.7%
  • $246M
  • 1 add 1 reduce 2 exits

In 2026 Q2 Richard Pzena added to Globe Life, Tweedy, Browne Co. trimmed, and George Soros and Lee Ainslie sold out.

Who owns this now

Largest portfolio weights among holders, up to 0.7% (Richard Pzena, Pzena Investment Management). Not free-float ownership.

  1. Richard Pzena Add 0.71%
  2. Tweedy, Browne Co. Reduce 0.30%

Who owns GL

Sorted by value, long equity only, as of 2026 Q2.

History
Richard Pzena, Pzena Investment Management 0.71%, was 0.46% Add +32.1% 1,355,811 $242M History
Tweedy, Browne Co. 0.30%, was 0.31% Reduce −19.6% 22,364 $4M History
George Soros, Soros Fund Management exited 2026 Q2 Last 2026 Q1 0.09% Exit −0.09% 59,695 $8.3M History
Lee Ainslie, Maverick Capital exited 2026 Q2 Last 2026 Q1 0.02% Exit −0.02% 11,081 $1.5M History

2 current, 2 exited last period, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by GL's executives, directors and 10% owners in the last 12 months, from their Form 4s

All GL insider trades
  • None no insider bought on the open market
  • $89.9M sold by 12 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Robert Edward Hensley EVP & Chief Investment Officer
    Sale
    $1.7M 10,000 shares at $170.07 45% of stake
    Traded Sep 22 Filed Sep 23
    ↗
  2. Robert Brian Mitchell EVP, General Counsel and CRO
    Sale
    $4.2M 23,000 shares at $183.34 74% of stake
    Traded Aug 7 Filed Aug 10
    ↗
  3. James Matthew Darden CEO
    Sale
    $9.1M 50,000 shares at $182.43 46% of stake
    Traded Jul 31 Filed Aug 3
    ↗
  4. Thomas Peter Kalmbach CFO
    Sale
    $3.8M 21,000 shares at $180.06 29% of stake
    Traded Jul 30 Filed Jul 30
    ↗
  5. Michael Clay Majors EVP - Chief Strategy Officer
    Sale
    $6.6M 37,000 shares at $178.64 41% of stake
    Traded Jul 29 Filed Jul 30
    ↗
  6. Thomas Peter Kalmbach CFO
    Sale
    $4.6M 25,650 shares at $178.58 34% of stake
    Traded Jul 28 Filed Jul 29
    ↗
  7. Dolores L Skarjune EVP and Chief Admin. Officer
    Sale
    $331K 1,850 shares at $179.18 12% of stake
    Traded Jun 30 Filed Jun 30
    ↗
  8. Cheryl Alston Director
    Sale
    $1.5M 8,258 shares at $179.24 33% of stake
    Traded Jun 25 Filed Jun 26
    ↗
  9. Rebecca E Zorn EVP & Chief Talent Officer
    Sale
    $340K 2,000 shares at $170.10 10% of stake
    Traded Jun 18 Filed Jun 22
    ↗
  10. Dolores L Skarjune EVP and Chief Admin. Officer
    Sale
    $694K 4,175 shares at $166.18 23% of stake
    Traded Jun 12 Filed Jun 16
    ↗
  11. Frank M Svoboda CEO
    Sale
    $3.3M 20,000 shares at $165.78 27% of stake
    Traded Jun 11–12 Filed Jun 15
    ↗
  12. Robert Brian Mitchell EVP, General Counsel and CRO
    Sale
    $93K 600 shares at $155.56 1.3% of stake
    Traded May 29 Filed May 29
    ↗
  13. Thomas Peter Kalmbach CFO
    Sale
    $1.2M 7,936 shares at $156.59 14% of stake
    Traded May 22 Filed May 26
    ↗
  14. Frank M Svoboda CEO
    Sale
    $3.1M 20,000 shares at $156.68 27% of stake
    Traded May 22 Filed May 26
    ↗
  15. Thomas Peter Kalmbach CFO
    Sale
    $1.9M 11,903 shares at $156.61 20% of stake
    Traded May 19 Filed May 20
    ↗

Also filed in the last 12 months, not counted as buying or selling: 40 option exercises, 33 stock grants, 21 share withholdings for taxes, and 12 gifts.

Congress

3 members of Congress traded GL in the last three years: 2 buys and 2 sales. 2 members listed it in 2025 annual reports.

All Congress trades
  1. Alan Armstrong R-OK Buy $1K–$15K Mar 27 filed Jul 21
  2. Lisa C. McClain R-MI-9Spouse Sell $1K–$15K Jul 10, 2025 filed Aug 13, 2025
  3. Lisa C. McClain R-MI-9Spouse Buy $1K–$15K Jun 17, 2025 filed Aug 13, 2025
  4. Susan M. Collins R-MESpouse Sell $15K–$50K Aug 5, 2024 filed Sep 13, 2024

SEC filings

Recent issuer filings from EDGAR, 12 shown.

Filed Form Detail Links
8-K 2.02,9.01 Filing Doc
8-K 5.02 Filing Doc
10-Q 10-Q (Q2 2026) Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 1.01,9.01 Filing Doc
10-Q 10-Q (Q1 2026) Filing Doc
SCHEDULE 13G — Filing Doc
8-K 5.02,5.07 Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G — Filing Doc
8-K 2.02,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc

Source: SEC EDGAR submissions, updated 2 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $5.45B $5.78B $5.99B
Gross profit $1.26B — —
Gross margin * 23.1% — —
Net income $0.971B $1.07B $1.16B
Net margin * 17.8% 18.5% 19.4%

Balance sheet

Metric FY2023 FY2024 FY2025
Total assets $26.92B $29.08B $30.81B
Total equity $4.49B $5.31B $5.97B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $1.48B $1.4B $1.4B
Cash from investing -$926.15M -$641.52M -$643.62M
Cash from financing -$541.49M -$715.84M -$768.05M
Net change in cash $10.6M $62.17M -$20.62M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.